Lineage Cell Therapeutics, Inc. (LCTX) SEC Filings — 2025
15 SEC filings for Lineage Cell Therapeutics, Inc. (LCTX) in 2025.
Filings
- Lineage Cell Therapeutics, Inc. 8-K Filing — 8-K · Nov 28, 2025
- Lineage Cell Therapeutics, Inc. 8-K Filing — 8-K · Nov 24, 2025
- Lineage Cell Therapeutics Files 8-K — 8-K · Nov 12, 2025
- LCTX Net Loss Widens to $64.3M on Warrant Liability, Intangible Impairment — 10-Q · Nov 6, 2025
- Lineage Cell Therapeutics Files 8-K — 8-K · Aug 26, 2025
- Lineage Cell Therapeutics' Q2 Loss Widens Amid R&D Spend — 10-Q · Aug 12, 2025
- Lineage Cell Therapeutics Files 8-K on Corporate Governance — 8-K · Jul 2, 2025
- Lineage Cell Therapeutics Files 8-K — 8-K · Jun 23, 2025
- Lineage Cell Therapeutics Files Proxy Supplement — DEFA14A · Jun 11, 2025
- Lineage Cell Therapeutics Appoints New Auditor — 8-K · Jun 9, 2025
- Lineage Cell Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Lineage Cell Therapeutics Files 8-K — 8-K · May 1, 2025
- Lineage Cell Therapeutics DEF 14A: Executive Compensation Details — DEF 14A · Apr 29, 2025
- Lineage Cell Therapeutics Files 2024 10-K — 10-K · Mar 10, 2025
- Lineage Cell Therapeutics Files 8-K — 8-K · Jan 27, 2025